Vichem Is A Hungarian Biotech Research Company And Performs Advanced Medicinal Chemistry In The Kinase Inhibitory Field Based On Its Uniquein House Developednested Chemical Librarya Cncltechnologywith Over 20 Years Of Experience In Kinase Inhibitory Chemistry We Have Established An Outstanding Knowledge Base That Has Helped To Develop The Nclour Library Is Organized Around More Than 110 Core Structures And More Than 600 Scaffoldsand Contains Inhibitors Against More Than 160 Kinasesproviding The Most Diverse Kinase Inhibitory Library Available For Drug Researchin Around A Year We Candeliver A Novel Patentablesubmicromolar Lead Compound Against A Selected Kinase With About 4 5 Research Cycles Using Our Innovative Nclmasterkeypharmacophore And Scaffold Hopping Technologies Our Tool Compound Library Tcltechnology Enables Us To Perform Selectivity Profiling And Off Target Identification Tcl Compounds Can Be Labelled With Fluorescent Dyes A Used As Tracersvichem Is Highly Skilled In Developing Preclinical Candidates With Lead Optimization For Efficacy And Admet Properties Vichem Has Nm Lead Compounds Against 20 Kinase Targets In Cancerinflammatory And Infectious Diseasesvichem Has Developed Lead Compounds Against Various Kinase Targets For Its Collaborative Partnersvichem Has Lead Compounds And Or Early Preclinical Candidates For Tbinfluenzaaids And 5 Pathological Kinase Targetsvichem Established Partnership With Various Europeanamerican And Japanese Institutions And Companiesparticipates In Several Fp7 Projects
